S&P 500   3,864.16 (+0.23%)
DOW   31,079.45 (+0.39%)
QQQ   328.69 (+0.18%)
AAPL   143.56 (+0.45%)
MSFT   232.05 (+1.10%)
FB   278.63 (+0.22%)
GOOGL   1,892.79 (-0.08%)
AMZN   3,295.00 (+0.03%)
TSLA   892.15 (+1.29%)
NVDA   543.00 (-0.57%)
BABA   263.60 (+0.85%)
CGC   33.13 (+0.67%)
GE   12.09 (+10.01%)
MU   81.69 (+0.50%)
AMD   95.03 (+0.96%)
NIO   60.34 (+0.58%)
T   29.05 (-0.21%)
F   11.29 (-2.00%)
BA   205.51 (+1.06%)
DIS   173.59 (+0.99%)
NFLX   555.10 (-0.30%)
GILD   67.50 (-0.97%)
S&P 500   3,864.16 (+0.23%)
DOW   31,079.45 (+0.39%)
QQQ   328.69 (+0.18%)
AAPL   143.56 (+0.45%)
MSFT   232.05 (+1.10%)
FB   278.63 (+0.22%)
GOOGL   1,892.79 (-0.08%)
AMZN   3,295.00 (+0.03%)
TSLA   892.15 (+1.29%)
NVDA   543.00 (-0.57%)
BABA   263.60 (+0.85%)
CGC   33.13 (+0.67%)
GE   12.09 (+10.01%)
MU   81.69 (+0.50%)
AMD   95.03 (+0.96%)
NIO   60.34 (+0.58%)
T   29.05 (-0.21%)
F   11.29 (-2.00%)
BA   205.51 (+1.06%)
DIS   173.59 (+0.99%)
NFLX   555.10 (-0.30%)
GILD   67.50 (-0.97%)
S&P 500   3,864.16 (+0.23%)
DOW   31,079.45 (+0.39%)
QQQ   328.69 (+0.18%)
AAPL   143.56 (+0.45%)
MSFT   232.05 (+1.10%)
FB   278.63 (+0.22%)
GOOGL   1,892.79 (-0.08%)
AMZN   3,295.00 (+0.03%)
TSLA   892.15 (+1.29%)
NVDA   543.00 (-0.57%)
BABA   263.60 (+0.85%)
CGC   33.13 (+0.67%)
GE   12.09 (+10.01%)
MU   81.69 (+0.50%)
AMD   95.03 (+0.96%)
NIO   60.34 (+0.58%)
T   29.05 (-0.21%)
F   11.29 (-2.00%)
BA   205.51 (+1.06%)
DIS   173.59 (+0.99%)
NFLX   555.10 (-0.30%)
GILD   67.50 (-0.97%)
S&P 500   3,864.16 (+0.23%)
DOW   31,079.45 (+0.39%)
QQQ   328.69 (+0.18%)
AAPL   143.56 (+0.45%)
MSFT   232.05 (+1.10%)
FB   278.63 (+0.22%)
GOOGL   1,892.79 (-0.08%)
AMZN   3,295.00 (+0.03%)
TSLA   892.15 (+1.29%)
NVDA   543.00 (-0.57%)
BABA   263.60 (+0.85%)
CGC   33.13 (+0.67%)
GE   12.09 (+10.01%)
MU   81.69 (+0.50%)
AMD   95.03 (+0.96%)
NIO   60.34 (+0.58%)
T   29.05 (-0.21%)
F   11.29 (-2.00%)
BA   205.51 (+1.06%)
DIS   173.59 (+0.99%)
NFLX   555.10 (-0.30%)
GILD   67.50 (-0.97%)
Log in
OTCMKTS:OCPNY

Olympus Stock Forecast, Price & News

$19.93
-0.32 (-1.58 %)
(As of 01/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$19.68
Now: $19.93
$20.00
50-Day Range
$19.21
MA: $20.92
$22.01
52-Week Range
$11.09
Now: $19.93
$22.99
Volume30,381 shs
Average Volume27,249 shs
Market Capitalization$27.32 billion
P/E Ratio71.18
Dividend Yield0.35%
Beta0.68
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through five segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, Imaging Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, video and other endoscopes system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Imaging Business segment provides digital cameras, IC and voice recorders, mirrorless interchangeable-lens cameras, and interchangeable lenses. The Others segment offers biomedical materials. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and GI- and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
Olympus logo

MarketRank

Overall MarketRank

1.19 out of 5 stars

Medical Sector

829th out of 1,922 stocks

Structural Clay Products Industry

1st out of 3 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Structural clay products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:OCPNY
CUSIPN/A
CIKN/A
Phone813-3340-2111
Employees35,174
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.32 billion
Cash Flow$0.80 per share
Book Value$2.51 per share

Profitability

Net Income$475.36 million

Miscellaneous

Outstanding Shares1,370,915,000
Market Cap$27.32 billion
Next Earnings Date2/4/2021 (Estimated)
OptionableNot Optionable
$19.93
-0.32 (-1.58 %)
(As of 01/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OCPNY News and Ratings via Email

Sign-up to receive the latest news and ratings for OCPNY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Olympus (OTCMKTS:OCPNY) Frequently Asked Questions

How has Olympus' stock price been impacted by Coronavirus (COVID-19)?

Olympus' stock was trading at $17.6660 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OCPNY stock has increased by 12.8% and is now trading at $19.93.
View which stocks have been most impacted by COVID-19
.

Is Olympus a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Olympus in the last twelve months. There are currently 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" Olympus stock.
View analyst ratings for Olympus
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Olympus?

Wall Street analysts have given Olympus a "Strong Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Olympus wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Olympus' next earnings date?

Olympus is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Olympus
.

How were Olympus' earnings last quarter?

Olympus Co. (OTCMKTS:OCPNY) issued its quarterly earnings results on Wednesday, August, 5th. The company reported ($0.02) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The business had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.29 billion. Olympus had a net margin of 5.34% and a trailing twelve-month return on equity of 10.82%.
View Olympus' earnings history
.

Is Olympus a good dividend stock?

Olympus pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.35%. The dividend payout ratio of Olympus is 19.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Olympus will have a dividend payout ratio of 11.48% next year. This indicates that Olympus will be able to sustain or increase its dividend.
View Olympus' dividend history.

Who are some of Olympus' key competitors?

Who are Olympus' key executives?

Olympus' management team includes the following people:
  • Hiroyuki Tsuji, Director
  • Mr. Yasuo Takeuchi, Pres, CEO, Representative Exec. Officer & Director (Age 64)
  • Mr. Chikashi Takeda, Exec. Officer & CFO (Age 59)
  • Mr. Nacho Abia, COO & Exec. Officer (Age 53)
  • Mr. Akihiro Taguchi, CTO & Exec. Officer (Age 63)
  • Mr. Stefan Kaufmann, Chief Admin. Officer, Exec. Officer & Director (Age 53)
  • Ms. Donna Miller, Head of HQ Legal and Global Gen. Counsel
  • Ms. Caroline H. West, Chief Compliance Officer (Age 63)
  • Mr. Mark Miller, Global Chief Communications Officer
  • Shigeto Ohtsuki, Corp. Officer & HR Head

What is Olympus' stock symbol?

Olympus trades on the OTCMKTS under the ticker symbol "OCPNY."

How do I buy shares of Olympus?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Olympus' stock price today?

One share of OCPNY stock can currently be purchased for approximately $19.93.

How big of a company is Olympus?

Olympus has a market capitalization of $27.32 billion and generates $7.32 billion in revenue each year. The company earns $475.36 million in net income (profit) each year or $0.36 on an earnings per share basis. Olympus employs 35,174 workers across the globe.

What is Olympus' official website?

The official website for Olympus is www.olympus-global.com.

How can I contact Olympus?

Olympus' mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The company can be reached via phone at 813-3340-2111 or via email at [email protected]

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.